参芪地黄降糖颗粒联合二甲双胍对妊娠期糖尿病妊娠结局的影响被引量：6

导出

摘要目的:分析参芪地黄降糖颗粒和二甲双胍联合治疗对妊娠期糖尿病(GDM)妊娠结局的影响。方法:选择我院2017年4月—2018年4月诊治的86例GDM患者为研究对象,依据随机数表法分组,每组43例。对照组给予二甲双胍治疗,研究组给予二甲双胍和参芪地黄降糖颗粒联合治疗。比较两组疗效、治疗前后血糖指标和妊娠结局。结果:研究组疗效总有效率(93.02%,40/43)明显高于对照组(74.42%,32/43),差异具有统计学意义(P<0.05)。治疗后,两组2 hPG、FPG和HbAlc水平均下降,研究组低于对照组,两组比较差异显著(P<0.05)。研究组不良妊娠总发生率(9.32%,4/43)显著低于对照组(25.59%,11/43),差异具有统计学意义(P<0.05)。结论:给予参芪地黄降糖颗粒和二甲双胍联合治疗的GDM疗效显著提升,血糖指标和妊娠结局明显改善。

作者江海芳

机构地区广州市白云区京溪街社区卫生服务中心

出处《北方药学》 2020年第2期40-41,共2页 Journal of North Pharmacy

基金 (广东省援疆科技项目)喀什地区疏附县维吾尔族妇女妊娠糖尿病早期诊断的临床应用研究,课题编号:2017B02024043。

关键词妊娠期糖尿病二甲双胍参芪地黄降糖颗粒妊娠结局

分类号 R714.256 [医药卫生—妇产科学]

引文网络
相关文献

参考文献5

1娜仁其木格,李冬梅,米林香,梁宏伟.中国妊娠期糖尿病患病率的Meta分析[J].中国循证医学杂志,2018,18(3):280-285. 被引量：140
2黄铭钧,李瑞满.妊娠期糖尿病的影响因素及其对不良妊娠结局的影响[J].暨南大学学报（自然科学与医学版）,2017,38(3):264-268. 被引量：40
3张琳,郑丽,戴晖,杨爱华.二甲双胍对妊娠期糖尿病患者新生儿安全性影响的系统评价[J].医药导报,2018,37(9):1119-1126. 被引量：17
4苗志荣,吴红花.妊娠期糖尿病诊断与治疗研究进展[J].中国糖尿病杂志,2017,25(4):365-370. 被引量：108
5任茜,王育璠.妊娠期糖尿病诊断新进展[J].世界临床药物,2013,34(9):513-517. 被引量：12

二级参考文献67

1Sereday MS, Damiano MM, Gonzalez CD, et al. Diagnostic criteria for gestational diabetes in relation to pregnancy outcome [J]. Diabetes Complications, 2003, 17 (3) : 115-119.
2Jenum AK, Morkrid K, Sletner L, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified international association of diabetes and pregnancy study groups criteria: a population-based cohort study [J]. Eur J Endoerinol, 2012, 166 (2) : 317-324.
3National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance EJl. Diabetes, 1979, 28 (12) : 1039-1057.
4Carpenter MW, Coustan DR. Criteria for screening test for gcstational diabetes [J]. Am J Obstet Gynecol, 1982, 14 (4): 768.
5International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care, 2010, 33 (3) : 676-82.
6HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes [J]. N Engl J Med, 2008, 358 (19) : 1991-2002.
7Coustan DR, Lowe LP, Metzger BE. The hyperglycemia and adverse pregnancy outcome (HAPO) study: can we use the results as a basis for change [J]. J Matern Fetal Neonatal Med, 2010, 23 (3) : 204-209.
8HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics[J]. Diabetes, 2009, 58 (2) : 453-459.
9TaUarigo L, Giampietro O, Penno G, et al. Relation of glucose tolerance to complications of pregnancy in nondiabetic women [J]. N Engl J Med, 1986, 315 (16) : 989-992.
10Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes [J]. N Engl J Med, 2005, 352 (24) : 2477-2486.